Background: The prognostic value of early magnetic resonance imaging (MRI) in dogs after traumatic brain injury (TBI) remains unclear.
T raumatic brain injury (TBI) is defined as structural injury or physiological disruption of the brain induced by an external force. In human medicine, TBI is indicated clinically by the acute onset of at least one of the following: a period of loss of or decreased consciousness, alteration in mental status, neurologic deficits, presence of an intracranial lesion, or some combination of these.
1 Not all the patients exposed to head trauma will suffer from TBI.
1 A recent singlecenter retrospective study reported that up to 25% of dogs with severe blunt trauma suffer from TBI.
2 Dogs with TBI are assessed clinically using the modified Glasgow coma scale (MGCS), which evaluates 3 categories: motor activity, brainstem reflexes, and level of consciousness. 3, 4 Each category is scored from 1 to 6 (lower score assigned to worse neurologic status), and the category scores are added together to determine the patient's total modified Glasgow coma score (Table 1 ). The MGCS total score ranges from 3 to 18, with the lowest score representing the worst neurologic status and the lowest probability of survival within the first 48 hours after head trauma. 4 Posttraumatic epilepsy (PTE) is among the most common form of acquired epilepsy in humans. 5 The onset of seizures after TBI has been categorized into immediate (<24 hours after TBI), early (within a week after TBI), and late (>1 week after TBI) onset. 5 Focal brain lesions in the frontal, temporal and parietal lobes, bilateral contusions, depressed fractures, midline shift >5 mm, subdural hematomas, decreased brain volume, intraparenchymal hemorrhage, and occurrence of seizures within the first week after TBI are important risk factors for PTE in humans. [5] [6] [7] [8] Traumatic brain injury in dogs recently has been associated with significant risk of developing PTE with an incidence up to 6.8%. 9, 10 Moreover, the risk of developing PTE increases with the severity of TBI. 9, 10 The role of neuroimaging in human patients with TBI is still emerging.
1 Currently, computed tomography (CT) is the modality of choice as a diagnostic tool for acute TBI.
1 However, MRI (1.5 Tesla) has sensitivity superior to that of CT for small focal traumatic intracranial lesions in patients with TBI and also results in fewer artifacts when assessing the brainstem. [11] [12] [13] Recent studies in humans have determined the value of MRI in patients with TBI. 14-18 More severe brain contusion has been associated with poorer 3-month outcome based on MRI in a recent prospective multicenter observational study in humans. 17 To the best of the authors' knowledge, the prognostic value of early MRI after TBI in dogs has not been studied previously. The aim of this study was to determine whether MRI findings are associated with prognosis after TBI in dogs.
Material and Methods

Study Population and Clinical Evaluation
The medical records of all dogs presented to the Animal Health Trust from April 2000 to August 2012 were reviewed. Inclusion criteria were as follows: (1) TBI based on clinical history, (2) no known history of intracranial central nervous system disease unrelated to the TBI, (3) neurologic examination documented in the medical record and MGCS recorded at presentation, 3 (4) minimum follow-up of 48 hours, and (5) 1.5 T MRI performed in the first 14 days after TBI.
Data retrieved from the medical records included signalment, history, physical and neurologic examination findings at presentation, presence of seizures after TBI, treatment, and outcome. Seizures were classified as immediate when the first seizure occurred <24 hours after TBI, early when it occurred within a week after TBI and late when it occurred >1 week after TBI.
Imaging Protocol and Analysis
Magnetic resonance imaging was performed using a 1.5 Tesla scanner.
a T2-weighted (T2W) fast spin echo (FSE) images were acquired in dorsal, sagittal, and transverse planes. Additional sequences included T2* gradient echo, T2-fluid attenuation inversion recovery, and T1-weighted FSE sequences before and after bolus administration of gadopentetate dimeglumine b at a dosage of 0.1 mL/kg of body weight. Slice thickness ranged from 2 to 4 mm.
The MRI findings were graded by three of the authors (E.B., F.M., and R.D.) who were blinded to the clinical findings. Disagreement was solved by consensus. Severity and location of lesions were classified based on a modified MRI grading system, 19 as follows: Grade I-normal parenchyma; Grade IIlesions only affecting the cerebral hemisphere, cerebellar parenchyma, or both without midline shift; Grade III-lesions only affecting the cerebral hemisphere, cerebellar parenchyma, or both and causing midline shift; Grade IV-lesions affecting corpus callosum, thalamus, or basal nuclei with or without any of the foregoing lesions of lesser grades; Grade V-unilateral lesions in the brainstem with or without any of the foregoing lesions of lesser grades; Grade VI-bilateral lesions affecting the brainstem with or without any of the foregoing lesions of lesser grades (Fig 1) .
The percentage of midline shift was calculated on transverse T2W-FSE images. The midline shift was measured as the distance of maximum shift from the midline using commercial software.
c This value was multiplied by 100 and divided by the distance from the midline to the convexity surface at the same level to calculate the percentage of midline shift.
The type of brain herniation 20 also was recorded as: herniation through the foramen magnum, caudal transtentorial herniation (CTH), rostral transtentorial herniation, subfalcine, and herniation through a fracture site (HFS). The extent of intraparenchymal damage (lesion[s] size) was measured using the software and recorded as 0, <25, 25-50, or >50% based on transverse, dorsal, and sagittal T2W-FSE images. Skull fractures were classified as open or closed, and depressed or nondepressed.
Outcome Measures
Short-term outcome was defined as survival or nonsurvival at 48 hours after TBI. Long-term outcome was assessed, when possible, at 3, 6, 12, and 24 months after TBI. Follow-up information at 3, 6, 12, and 24 months was obtained by telephone consultation with the owner, referring veterinarian, or both and combined with information from medical records. The outcome scale comprised 4 scores: (score 0) dead or euthanized because of the severity of the clinical presentation; (score 1) poor recovery: the dog had severe neurologic deficits or did not improve; (score 2) good recovery: the dog improved but still had visible mild neurologic deficits, required antiepileptic medication, or both; (score 3) excellent recovery: the dog was considered normal and did not require antiepileptic medication.
Statistical Analysis
Spearman correlation was used to test for correlations of MGCS at presentation and follow-up at 3, 6, 12, and 24 months with the following risk factors: MRI grade, intraparenchymal lesion percentage, and percentage of midline shift. Mann-Whitney U-tests were used to compare MGCS at presentation and followup scores between various binomial (yes/no) risk factor groups (presence of midline shift, brain herniation, brain herniation types, fractures, fracture types [depressed or nondepressed], open 
Results
A total of 50 dogs fulfilled the inclusion criteria. Of these, 11 (22%) were intact females, 12 (24%) were intact males, 17 (34%) were spayed females, and 10 (20%) were castrated males. The median age at presentation was 3 years (range, 2 months to 12 years). The median body weight was 8 kg (range, 0.9-45).
Breeds represented included crossbreed (n = 5), Toy poodle (4), Yorkshire Terrier (3), Dachshund (2), Jack Russell Terrier (2), Pomeranian (2), Labrador (2), Hungarian Vizsla (2), Cavalier King Charles Spaniel The most common cause of TBI was road traffic accident (RTA) in 20 dogs (40%) followed by canine attack in 9 dogs (18%), a fall in 9 dogs (18%), being hit by an object in 8 dogs (16%), and kicked by a horse in 4 dogs (8%).
The median MGCS at presentation was 16 (range, 8-18). All dogs were hospitalized and received standard treatment for stabilization after TBI.
1,21 Two dogs were presented in status epileptics and therefore MGCS could not be assessed at presentation.
Imaging Findings
Median time interval between TBI and MRI was 1 day (range, <1 day to 14 days). Thirty-three dogs (66%) had an abnormal MRI. The median MRI grade was III (range, I-VI A significant negative correlation was identified between MGCS at presentation and MRI grade (r = À0.63, P < .001) and for MGCS and size of intraparenchymal lesions (r = À0.58, P < .001).
The risk of developing seizures increased with severity of TBI. The presence of seizures was significantly associated with higher size (>25%) of intraparenchymal lesions (P = .0054). Twenty-three (46%) dogs had skull fractures. Twelve of these 23 (52%) dogs developed seizures. Twelve dogs (52%) had open fractures and 11 (48%) had closed fractures. Seventeen dogs (74%) had depressed fractures.
Midline shift was present in 19 dogs (38%). The median percentage of midline shift was 8.3% (range, 2.6-22.8). Brain herniation was present in 10 dogs (20%). Eight dogs had brain HFS, 3 had FM, 3 had CTH, and 2 had SFH.
Seizure occurrence was significantly associated with HFS (P = .0122), CTH (P = .0172), and skull fractures (P = .0279).
The MGCS score at presentation was significantly lower in dogs with brain herniation than in those without herniation (P = .0191), and specifically in dogs with HFS than in those without HFS (P = .04).
Outcome
Eighteen dogs (36%) had seizures at some point after TBI (median, 0.5 days; range, 0-427). Eight dogs developed seizures immediately, 6 dogs developed early seizures, and 4 dogs developed late onset seizures. A total of 5 dogs exhibited recurrent seizures (10%) indicating development of PTE. None of these dogs had experience seizures before head trauma. The median number of days before PTE onset was 119 (range, 0-427). Fifteen dogs with seizures were started on antiepileptic medication: 11 dogs on phenobarbitone, 2 dogs on potassium bromide, 1 dog on phenobarbitone and potassium bromide, and 1 dog on levetiracetam. Antiepileptic medication was discontinued in 7 dogs within a year after TBI because of the lack of seizure activity. Three dogs were lost to follow-up. The remaining 4 dogs were in the group with PTE. The owner of 1 dog with PTE declined to start antiepileptic medication because of the low frequency of epileptic events (3 episodes per year). Three dogs were started on prophylactic antiepileptic medication (phenobarbitone) immediately after TBI and the medication was discontinued in 2 dogs after 1 year because of lack of seizure activity. The remaining dog developed severe cluster seizures 3 months after TBI and was euthanized.
Five dogs (10%) underwent surgical decompression. The prevalence of seizures was higher in dogs that underwent surgical decompression (4/5; 80%) compared to dogs that did not undergo surgical decompression (14/45; 31.1%; P = .0307). Two of these 4 dogs had seizures after TBI and before surgical intervention. The other 2 remaining dogs with surgical decompression developed late onset seizures.
Three dogs (6%) were dead (nonsurvivors) 48 hours after TBI. Death at 48 hours was significantly associated with herniation (P < .001), HFS (P = .0135), FM (P < .001), CTH (P = .0398), SFH (P = .0075), and depressed fractures (P = .0128). The size of intraparenchymal lesions was significantly higher (>25%) in dogs that were dead at 48 hours (P = .0420) compared to those that were alive at 48 hours.
Forty-one dogs had follow-up at 3 months with a median outcome scale score of 2 (range, 1-3). One dog was euthanized at 4 months because of severe neurologic signs. Forty-two dogs had follow-up at 6 months with a median score of 2 (range, 0-3). Thirty-eight dogs had follow-up at 12 months with a median score of 2 (range, 2-3). Thirty-five dogs had follow-up at 24 months with a median score of 3 (range, 2-3).
A significant negative correlation was identified between MRI grade and scores at 3 (r = À0.44, P = .0027) and 6 months (r = À0.37, P = .0160; Fig 2) . A significant negative correlation was identified between percentage of midline shift and outcome score at 6 (r = À0.53, P = .0353), 12 (r = À0.56, P = .0291), and 24 months (r = À0.81, P < .001). A significant negative correlation was identified between size of intraparenchymal lesions and follow-up scores at 3 (r = À0.43, P = .0037), 6 (r = À0.49, P = .001), 12 (r = À0.47, P = .0027), and 24 months (r = À0.36, P = .0332; Fig 3) . A positive correlation was identified between follow-up scores at 3 (r = 0.46, P = .0018) and 6 (r = 0.32, P = .0403) months with MGCS at presentation.
Follow-up scores at 3, 6, 12, and 24 months were significantly lower in dogs that had brain herniation or fractures (Fig 4) . Follow-up scores in dogs that had HFS were significantly lower at 6 and 12 months. Follow-up scores in dogs that had CTH were significantly lower at 6, 12, and 24 months. Follow-up scores in dogs that had FM herniation were significantly lower at 3 and 6 months. Follow-up scores in dogs that had surgical decompression were significantly lower at 3, 6, and 12 months.
Discussion
Traumatic brain injury is an important cause of morbidity and mortality in dogs. 2 In agreement with previous studies in dogs, RTA was the most common cause of TBI in our study.
2,9,10
There is growing recognition that prediction of outcome in humans after TBI based only on the Glasgow coma scale is very limited. 22 Recent studies have focused on MRI findings as predictors of clinical out-come because of its high sensitivity for the detection of nonhemorrhagic contusions, brainstem lesions, and diffuse axonal injuries. 17, 18, [23] [24] [25] [26] MRI analysis and grading reported in this study appear to have clinical relevance because of their significant correlation with outcome. This study used a grading system modified from human medicine, where the severity and location of the lesions were taken into account.
19 Brainstem lesions have been associated with poor outcome in humans with caudal and bilateral brainstem injuries detected on MRI having the poorest prognosis.
19, 23, 25 Similarly in this study, unilateral and bilateral brainstem lesions were respectively classified with the higher MRI grade (grade V and VI) and had significant negative correlation with MGCS at presentation and follow-up scores, which is consistent with previous studies in humans. 23, 25 The findings of this study also are in agreement with previous work in humans where poor outcome was significantly associated with brain herniation, skull fractures, and increased size of intraparenchymal lesions. 17, 27 Recent studies support the use of advanced MRI techniques in human patients with TBI, including diffusion tensor imaging and resting state functional MRI, which may help to better define the type of injury (diffuse axonal injury) and predict outcome. [28] [29] [30] Functional MRI was not performed in our study, but its use in veterinary medicine also may advance the ability to prognosticate and should be considered in the future.
One of the limitations of using MRI is that usually it is performed in referral centers and requires patients that are hemodynamically stable enough to undergo general anesthesia. This necessity could suggest that patients that undergo MRI are more likely to survive and that patients with severe TBI may not reach the referral center. A recent study reported that the risk of developing severe perianesthetic complications in dogs with intracranial lesions was nonsignificant compared with dogs without intracranial lesions and the overall severe complication rate was considered low (1.3%). 31 The ultimate anesthesia management goal in dogs with intracranial lesions is to maintain cerebral perfusion by controlling factors that have an effect on cerebral blood flow. This goal can be successful with the use of multimodal techniques, which are beyond the scope of our study. 31, 32 The mean time of performing MRI in this study was 1 day after TBI, but the number of dogs with severe TBI that did not reach our referral center is unknown.
Posttraumatic seizures can cause secondary brain injury, contributing to morbidity and mortality. 33 Previous studies have reported the incidence of epilepsy as 0.55-2% of all the dogs referred to veterinary hospitals. [34] [35] [36] Our study demonstrated that 10% of dogs with TBI develop PTE. Therefore, we can consider dogs with TBI to have a 5-to 18-fold increased risk of developing epilepsy compared to the general hospital population and based on the expected incidence of epilepsy. These results are similar to a recent study in which 6.6% of dogs with TBI developed PTE and had an 11.6-fold increased risk of developing epilepsy compared to the general hospital population. 9 Another recent study reported that late onset of seizures in dogs after TBI is greater than early onset of seizures (6.8% versus 3.5%). 10 This finding differs from our study in which the onset of immediate or early onset of seizures was greater than late onset of seizures (28% versus 8%). Four of the 5 dogs that developed PTE did not have any immediate or early onset of seizures. Therefore, in contrast to what is reported in the human literature, the early onset of seizures after TBI in dogs does not seem to be an important risk factor for development of PTE. 5 According to the 3rd edition of the guidelines of management of TBI in humans, 37 the use of antiepileptic medication is indicated to decrease the incidence of early posttraumatic seizures, but early posttraumatic seizures have not been associated with poorer outcome. In human medicine, the role of prophylactic antiepileptic medication in moderate to severe TBI is still debatable, but there are some recent studies that support their use. 38, 39 Randomized controlled doubleblinded trials may be necessary to investigate whether treatment (such as prophylactic antiepileptic medication) of these cases with increased risk of developing PTE can alter outcome.
This study is retrospective with heterogeneous design, including different ages of patients, antiepileptic treatments, and multiple forms of TBI (mild to severe TBI). Therefore, these results should be validated with prospective and multicenter studies. An additional limitation of this study is that outcome assessment was not performed blindly, because some information about the patient history was known. However, the authors do not think this situation affected the overall results of this study.
In summary, this study supports the prognostic value of MRI in dogs with TBI. The MRI classification proposed here could help identify dogs at higher risk of poorer outcome, which may allow modification of the management of these patients and assist in informing owners about the prognosis for survival and the possibility of developing PTE. 
